Valuation: J. B. Chemicals & Pharmaceuticals Limited

Capitalization 25TCr 292.24Cr 249.95Cr 232.8Cr 216.51Cr 400.16Cr 445.25Cr 2.79TCr 1.07TCr 12TCr 1.1TCr 1.07TCr 43TCr P/E ratio 2025
39x
P/E ratio 2026 * 31.7x
Enterprise value 25TCr 288.73Cr 246.95Cr 230.01Cr 213.91Cr 395.35Cr 439.91Cr 2.76TCr 1.05TCr 12TCr 1.08TCr 1.06TCr 43TCr EV / Sales 2025
6.42x
EV / Sales 2026 * 5.53x
Free-Float
45.74%
Yield 2025 *
0.71%
Yield 2026 * 0.92%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.26%
1 week-1.75%
Current month-4.25%
1 month-7.84%
3 months+2.15%
6 months-11.79%
Current year-12.81%
More quotes
1 week 1,604
Extreme 1604
1,649.95
1 month 1,604
Extreme 1604
1,849.95
Current year 1,303
Extreme 1303
1,916.85
1 year 1,303
Extreme 1303
2,029
3 years 802.18
Extreme 802.175
2,029
5 years 353.7
Extreme 353.7
2,029
10 years 114.15
Extreme 114.15
2,029
More quotes
Manager TitleAgeSince
Chief Executive Officer 52 05/10/2020
Director of Finance/CFO 45 23/02/2024
Chief Operating Officer 45 31/08/2020
Director TitleAgeSince
Director/Board Member 52 05/10/2020
Director/Board Member 49 10/02/2021
Director/Board Member 60 31/08/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.26%-1.75%-7.99%+103.83% 292.16Cr
+0.30%+1.58%-16.38%+145.07% 71TCr
-0.50%+0.57%+4.68%-10.78% 38TCr
-1.31%+1.67%+13.02%+26.23% 34TCr
-3.64%-2.74%-55.22%+8.38% 31TCr
-2.36%-1.23%+0.78%-21.80% 26TCr
-3.00%-1.93%-3.83%+16.05% 24TCr
-1.66%+1.10%-14.76%-6.40% 22TCr
-0.79%+3.00%-34.75%-10.94% 21TCr
-1.70%-1.00%-10.75%+19.56% 16TCr
Average -1.49%+0.32%-12.52%+26.92% 28.2TCr
Weighted average by Cap. -1.30%+0.64%-12.51%+38.50%
See all sector performances

Financials

2025 2026 *
Net sales 3.95TCr 46Cr 39Cr 37Cr 34Cr 63Cr 70Cr 439.92Cr 168.08Cr 1.85TCr 172.79Cr 169.23Cr 6.79TCr 4.37TCr 51Cr 44Cr 41Cr 38Cr 70Cr 78Cr 486.57Cr 185.9Cr 2.05TCr 191.11Cr 187.18Cr 7.51TCr
Net income 674.56Cr 7.86Cr 6.73Cr 6.26Cr 5.83Cr 11Cr 12Cr 75Cr 29Cr 315.96Cr 29Cr 29Cr 1.16TCr 800.88Cr 9.34Cr 7.99Cr 7.44Cr 6.92Cr 13Cr 14Cr 89Cr 34Cr 375.13Cr 35Cr 34Cr 1.38TCr
Net Debt -301.12Cr -3.51Cr -3Cr -2.8Cr -2.6Cr -4.81Cr -5.35Cr -34Cr -13Cr -141.04Cr -13Cr -13Cr -517.66Cr -904.85Cr -11Cr -9.02Cr -8.4Cr -7.82Cr -14Cr -16Cr -100.72Cr -38Cr -423.83Cr -40Cr -39Cr -1.56TCr
More financial data * Estimated data
Logo J. B. Chemicals & Pharmaceuticals Limited
J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing of medicated and herbal lozenges. All its lozenges (herbal, medicated and soft-centered) can be made in sugar and sugar-free options. It has implemented osmotic-controlled release oral drug delivery system (OROS) technology. It maintains a direct presence in Russia and South Africa, along with distributor relationships in the United States and various markets throughout Asia, Africa, and Latin America.
Employees
5,311
More about the company
Date Price Change Volume
11/25/11 1,608.35 -0.26% 2,346
10/25/10 1,612.55 -1.24% 4,032
09/25/09 1,632.80 +0.44% 3,817
08/25/08 1,625.60 -0.40% 2,951
07/25/07 1,632.10 -0.30% 6,082

Delayed Quote Bombay S.E., July 11, 2025 at 03:57 pm IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,608.35INR
Average target price
2,031.33INR
Spread / Average Target
+26.30%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. JBCHEPHARM Stock